During the past decade, Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie" are "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Alzheimer Disease" (1 trials), "Cytomegalovirus Infections" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie" in a lesser frequency.

Most popular intervention types in "Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ocrelizumab" (2 trials), "Avonex" (1 trials), "Fenebrutinib" (1 trials) and "Gantenerumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".